Рус
Latest news
6/22/2018 Database Update: Pharmaceutical Drug Import to Russia (April 2018)
Between January and April 2018, Russia imported 156.1 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms 0.9% higher than that of the same period of 2017, and 35.9 bln RUB worth of in-bulk drugs, which is 27% higher than those of the same period of 2017. In total, the dynamics in monetary terms are 0.5%.
6/15/2018 Rating of Russian Pharmacy Chains (Q1 2018)
Pharmacy chains have always developed with the money of the producer, first at the expense of commodity loans through distributors, later directly from the marketing budgets. There would not be anything wrong with that if some distortions did not occur from time to time at different stages of the system's operation.
6/8/2018 Rating of Russian Pharmaceutical Distributors (Q1 2018)
At the beginning of 2018, the Russian pharmaceutical market confidently stepped over the uncertain period of stagnation and then started to fall. If earlier it could happen only in certain sectors of the market, the retail could still improve the dynamics. Now the retail is in danger, which is about 70% of the Russian pharmaceutical market, so that the absolute majority of participants in the market will feel the consequences.
6/6/2018 Database Update: Pharmaceutical Drug Import from EEU Countries to Russia (April 2018)
Between January and April 2018, Russia imported 3.7 bin RUB worth of pharmaceutical drugs manufactured in the EEU countries (wholesale prices, VAT included), which is in monetary terms 58.2% higher than that of the same period of 2017. Despite the growth in monetary terms, in physical terms, the import amounted to around 3.7 mln units, which is 15.3% lower than that of the same period of 2017.
5/31/2018 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (April 2018)
Between January and April 2018, Russia dispatched 100.9 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms 6.4% lower than that of the same period of 2017. In physical terms, Russia produced 1.32 bln units of pharmaceuticals, which is 10.8% lower than that of the same period of 2017. The performance in April is nowhere near outstanding, with a 22.5% fall in monetary terms, which is the worst dynamics over the past 40 months. The dynamics in physical terms, while not as bad as in March, are still negative, -13.2%.
Our competences
RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.